CANDESARTAN Side Effects

6771694-0 | Atrial Natriuretic Peptide Increased, Blood Creatinine Increased, Glycosylated Haemoglobin Increased
on Mar 25, 2010 Male patient from UNITED STATES , 72 years of age, was treated with Candesartan (View Usage). Patient experienced the following unwanted or unexpected effects: atrial natriuretic peptide increased, blood creatinine increased, glycosylated haemoglobin increased. Candesartan dosage: . During the same period patient was treated with ONGLYZA (View Onglyza Review and Onglyza Label ), INSULIN INSULATARD NPH NORDISK (View Insulin Insulatard Nph Nordisk Review and Insulin Insulatard Nph Nordisk Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6686048-5 | Hypersensitivity
Patient was taking Candesartan (View Usage). Patient had the following side effects: hypersensitivity on Apr 09, 2010 from GERMANY Additional patient health information: Female patient , 84 years of age, weighting 143.3 lb, was diagnosed with hypertension, coronary artery disease (What is coronary artery disease?), gastrectomy, depression (What is depression?), pain (What is pain?) and. Candesartan dosage: . During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), NITROLINGUAL PUMPSPRAY (View Nitrolingual Pumpspray Review and Nitrolingual Pumpspray Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), PALLADON 4MG (View Palladon 4mg Review and Palladon 4mg Label ). Patient was hospitalized.

6186288-8 | Myelodysplastic Syndrome
Adverse event was reported on Apr 30, 2009 by a Male patient taking Candesartan (View Usage) (Dosage: ) was diagnosed with hypertension, hyperkalaemia, diabetes mellitus, diffuse large b-cell lymphoma recurrent and. Location: FRANCE , weighting 222.7 lb, After Candesartan was administered, patient had the following side effects: myelodysplastic syndrome. During the same period patient was treated with FLECAINE (View Flecaine Review and Flecaine Label ), KAYEXALATE (View Kayexalate Review and Kayexalate Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), GEMCITABINE HCL (Day 2 Every 2 Weeks) (View Gemcitabine Hcl Review and Gemcitabine Hcl Label ), RITUXIMAB (Day 1 Every 2 Weeks) (View Rituximab Review and Rituximab Label ), ENZASTAURIN (View Enzastaurin Review and Enzastaurin Label ), OXALIPLATIN (Day 2 Every 2 Weeks) (View Oxaliplatin Review and Oxaliplatin Label ).

5987385-X | Renal Failure Acute
on Dec 02, 2008 Female patient from JAPAN , 82 years of age, was treated with Candesartan (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Candesartan dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), FRUSEMIDE (View Frusemide Review and Frusemide Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ), NICORANDIL (View Nicorandil Review and Nicorandil Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.


5965369-5 | Asthma, Feeling Abnormal
on Nov 14, 2008 Male patient from JAPAN , 70 years of age, weighting 238.1 lb, was diagnosed with hypertension, thrombosis prophylaxis, asthma (What is asthma?), hypercholesterolaemia and was treated with Candesartan (View Usage). Patient had the following side effects: asthma (What is asthma?), feeling abnormal. Candesartan dosage: . During the same period patient was treated with FELODIPINE (View Felodipine Review and Felodipine Label ), DIPYRIDAMOLE (View Dipyridamole Review and Dipyridamole Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), SERETIDE (View Seretide Review and Seretide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ).

5904969-5 | Anaemia, Asthenia, Condition Aggravated, Depression, Fibromyalgia, Hallucination, Malaise, Memory Impairment, Pain
Patient was taking Candesartan (View Usage). After Candesartan was administered, patient had the following side effects: anaemia, asthenia, condition aggravated, depression (What is depression?), fibromyalgia, hallucination, malaise, memory impairment, pain (What is pain?) on Sep 19, 2008 from UNITED KINGDOM Additional patient health information: Female patient , weighting 216.1 lb, . Candesartan dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), ACETAMINOPHEN W/ CODEINE (1 Or 2 Tablets 4 Times A Day) (View Acetaminophen W/ Codeine Review and Acetaminophen W/ Codeine Label ), MOISTURISER (View Moisturiser Review and Moisturiser Label ).

5799855-8 | Hyperparathyroidism Secondary, Renal Failure
Adverse event was reported on Jun 25, 2008 by a Male patient taking Candesartan (View Usage) (Dosage: ) . Location: UNITED STATES , 60 years of age, Patient experienced the following unwanted or unexpected effects: hyperparathyroidism secondary, renal failure. During the same period patient was treated with 3 ANTIHYPERTENSIVE AGENTS (View 3 Antihypertensive Agents Review and 3 Antihypertensive Agents Label ).

5749700-1 | Anuria, Bladder Agenesis, Foetal Growth Retardation, Hypotension, Kidney Enlargement, Single Functional Kidney
on May 21, 2008 Male patient from UNITED KINGDOM , weighting 2.43 lb, was treated with Candesartan (View Usage). Patient had the following side effects: anuria, bladder agenesis, foetal growth retardation, hypotension, kidney enlargement, single functional kidney. Candesartan dosage: . During the same period patient was treated with BECLAMETHASONE (View Beclamethasone Review and Beclamethasone Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

5302180-2 | Chest Pain, Diastolic Dysfunction, Dyspnoea, Hypertension, Mitral Valve Incompetence, Renin Increased, Tricuspid Valve Incompetence, Ventricular Hypertrophy
on Apr 10, 2007 Male patient from JAPAN , 28 years of age, weighting 165.3 lb, was diagnosed with hypertension and was treated with Candesartan (View Usage). After Candesartan was administered, patient had the following side effects: chest pain (What is chest pain?), diastolic dysfunction, dyspnoea, hypertension, mitral valve incompetence, renin increased, tricuspid valve incompetence, ventricular hypertrophy. Candesartan dosage: . During the same period patient was treated with LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), URAPIDIL (View Urapidil Review and Urapidil Label ), RILMENIDINE (View Rilmenidine Review and Rilmenidine Label ). Patient was hospitalized.

5286374-0 | Renin Increased
Patient was taking Candesartan (View Usage). Patient experienced the following unwanted or unexpected effects: renin increased on Mar 30, 2007 from AUSTRIA Additional patient health information: Male patient , 28 years of age, weighting 165.3 lb, was diagnosed with hypertension and. Candesartan dosage: . During the same period patient was treated with LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), URAPIDIL (View Urapidil Review and Urapidil Label ), RILMENIDINE (View Rilmenidine Review and Rilmenidine Label ). Patient was hospitalized.

5283512-0 | Headache, Hypertension, Nausea, Restlessness
Adverse event was reported on Mar 23, 2007 by a Male patient taking Candesartan (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: NETHERLANDS , weighting 187.4 lb, Patient had the following side effects: headache (What is headache?), hypertension, nausea (What is nausea?), restlessness. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ZOPICLON (View Zopiclon Review and Zopiclon Label ), ATACAND (View Atacand Review and Atacand Label ).

5245134-7 | Circulatory Collapse, Gastroenteritis, Haemoglobin Decreased, Haemorrhage
on Feb 15, 2007 Female patient from GERMANY , 90 years of age, was diagnosed with hypertension, depression (What is depression?), coronary artery disease (What is coronary artery disease?), diabetes mellitus and was treated with Candesartan (View Usage). After Candesartan was administered, patient had the following side effects: circulatory collapse, gastroenteritis (What is gastroenteritis?), haemoglobin decreased, haemorrhage. Candesartan dosage: . During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ). Patient was hospitalized.

5167846-6 | Hypersensitivity
on Nov 15, 2006 Male patient from GUATEMALA , weighting 227.1 lb, was diagnosed with hypertension, diabetes mellitus non-insulin-dependent and was treated with Candesartan (View Usage). Patient experienced the following unwanted or unexpected effects: hypersensitivity. Candesartan dosage: . During the same period patient was treated with SYR 322 (View Syr-322 Review and Syr-322 Label ), NPH INSULIN (View Nph Insulin Review and Nph Insulin Label ), LOSARTAN POSTASSIUM (View Losartan Postassium Review and Losartan Postassium Label ). Patient was hospitalized.

5158518-2 | Hypersensitivity
Patient was taking Candesartan (View Usage). Patient had the following side effects: hypersensitivity on Nov 15, 2006 from GUATEMALA Additional patient health information: Male patient , weighting 227.1 lb, was diagnosed with hypertension, diabetes mellitus non-insulin-dependent and. Candesartan dosage: . During the same period patient was treated with SYR 322 (View Syr-322 Review and Syr-322 Label ), NPH INSULIN (View Nph Insulin Review and Nph Insulin Label ), LOSARTAN POSTASSIUM (View Losartan Postassium Review and Losartan Postassium Label ). Patient was hospitalized.

5131257-X | Orthostatic Hypotension, Renal Impairment
Adverse event was reported on Oct 09, 2006 by a Female patient taking Candesartan (View Usage) (Dosage: ) was diagnosed with hypertension, osteoarthritis (What is osteoarthritis?), meniere's disease (What is meniere's disease?), joint swelling and. Location: UNITED KINGDOM , 79 years of age, After Candesartan was administered, patient had the following side effects: orthostatic hypotension, renal impairment. During the same period patient was treated with ARTHROTEC (View Arthrotec Review and Arthrotec Label ), BETAHISTINE (View Betahistine Review and Betahistine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5010792-9 | Deafness, Pancreatic Abscess, Renal Impairment
on Mar 21, 2006 Male patient from SWEDEN , 56 years of age, was treated with Candesartan (View Usage). Patient experienced the following unwanted or unexpected effects: deafness, pancreatic abscess, renal impairment. Candesartan dosage: . During the same period patient was treated with NEBCINA (View Nebcina Review and Nebcina Label ).

4827277-2 | Acidosis, Apgar Score Low, Caesarean Section, Chorioamnionitis, Cranial Sutures Widening, Hypotonia Neonatal, Muscle Contractions Involuntary, Neonatal Asphyxia
on Oct 31, 2005 Female patient from GERMANY , weighting 3.75 lb, was diagnosed with hypertension and was treated with Candesartan (View Usage). Patient had the following side effects: acidosis, apgar score low, caesarean section, chorioamnionitis, cranial sutures widening, hypotonia neonatal, muscle contractions involuntary, neonatal asphyxia. Candesartan dosage: Stoped At 26 Weeks Gestation.. During the same period patient was treated with EBRANTIL (Stopped At 26 Weeks Gestation.) (View Ebrantil Review and Ebrantil Label ), HYDROCHLOROTHIAZIDE (Stopped At 26 Weeks Gestation.) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

4827276-0 | Caesarean Section, Chorioamnionitis, Pregnancy, Premature Baby, Premature Rupture Of Membranes
Patient was taking Candesartan (View Usage). After Candesartan was administered, patient had the following side effects: caesarean section, chorioamnionitis, pregnancy (What is pregnancy?), premature baby, premature rupture of membranes on Oct 31, 2005 from GERMANY Additional patient health information: Female patient , 34 years of age, was diagnosed with hypertension and. Candesartan dosage: Stopped At 25 Weeks Gestation.. During the same period patient was treated with EBRANTIL (Stopped At 26 Weeks Gestation.) (View Ebrantil Review and Ebrantil Label ), HYDROCHLOROTHIAZIDE (Stopped At 26 Weeks Gestation.) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

4740413-1 | Acute Myocardial Infarction, Ageusia
Adverse event was reported on Aug 04, 2005 by a Male patient taking Candesartan (View Usage) (Dosage: ) was diagnosed with essential hypertension, coronary artery atherosclerosis and. Location: SWITZERLAND , 95 years of age, Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, ageusia. During the same period patient was treated with NITRODERM (View Nitroderm Review and Nitroderm Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DANCOR (View Dancor Review and Dancor Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ).

4738560-3 | Apgar Score Low, Beta 2 Microglobulin Increased, Congenital Anomaly, Delayed Fontanelle Closure, Foetal Disorder, Haemoglobin Decreased, Kidney Enlargement, Kidney Malformation
on Jul 13, 2005 Female patient from FRANCE , weighting 7.05 lb, was diagnosed with essential hypertension and was treated with Candesartan (View Usage). Patient had the following side effects: apgar score low, beta 2 microglobulin increased, congenital anomaly, delayed fontanelle closure, foetal disorder, haemoglobin decreased, kidney enlargement, kidney malformation. Candesartan dosage: . During the same period patient was treated with METHYLDOPA (View Methyldopa Review and Methyldopa Label ).

4666388-1 | Leukocytosis, Metabolic Acidosis, Pancreatitis Acute, Renal Failure Acute, Respiratory Failure, Septic Shock, Ventricular Fibrillation
on Mar 21, 2005 Male patient from , 75 years of age, was diagnosed with hypertension, nephrolithiasis and was treated with Candesartan (View Usage). After Candesartan was administered, patient had the following side effects: leukocytosis, metabolic acidosis, pancreatitis acute, renal failure acute, respiratory failure, septic shock, ventricular fibrillation. Candesartan dosage: Taken For Over 1 Year. During the same period patient was treated with POTASSIUM CITRATE (View Potassium Citrate Review and Potassium Citrate Label ). Patient was hospitalized.

4621133-0 | Henoch-schonlein Purpura, Nephritis, Pitting Oedema
Patient was taking Candesartan (View Usage). Patient experienced the following unwanted or unexpected effects: henoch-schonlein purpura, nephritis, pitting oedema on Feb 04, 2005 from Additional patient health information: Male patient , 73 years of age, weighting 154.3 lb, was diagnosed with essential hypertension and. Candesartan dosage: 8 Mg Po.

4620711-2 | Circulatory Collapse, Pancreatitis Acute, Renal Failure, Respiratory Failure
Adverse event was reported on Mar 21, 2005 by a Male patient taking Candesartan (View Usage) (Dosage: 32 Mg Daily Po) . Location: , 75 years of age, Patient had the following side effects: circulatory collapse, pancreatitis acute, renal failure, respiratory failure.

4588303-1 | C-reactive Protein Increased, Haematuria, Henoch-schonlein Purpura, Nephrotic Syndrome, Pitting Oedema, Proteinuria, Rash Pruritic, Urticaria, Vasculitis
on Feb 04, 2005 Male patient from , 73 years of age, was diagnosed with essential hypertension and was treated with Candesartan (View Usage). After Candesartan was administered, patient had the following side effects: c-reactive protein increased, haematuria, henoch-schonlein purpura, nephrotic syndrome, pitting oedema, proteinuria, rash pruritic, urticaria, vasculitis (What is vasculitis?). Candesartan dosage: .